4//SEC Filing
Mack Gene 4
Accession 0001493152-25-001281
CIK 0001819411other
Filed
Jan 6, 7:00 PM ET
Accepted
Jan 7, 9:00 PM ET
Size
5.4 KB
Accession
0001493152-25-001281
Insider Transaction Report
Form 4
Mack Gene
DirectorCEO, President
Transactions
- Award
Stock Option (right to buy)
2025-01-06+271,325→ 271,325 totalExercise: $2.44Exp: 2035-01-06→ Common Stock (271,325 underlying)
Footnotes (1)
- [F1]The shares underlying the option shall vest as to 25% on January 6, 2026 and the remainder shall vest in 36 equal monthly installments thereafter, subject to Reporting Person's continuous service through each such vesting date.
Documents
Issuer
Gain Therapeutics, Inc.
CIK 0001819411
Entity typeother
Related Parties
1- filerCIK 0001737979
Filing Metadata
- Form type
- 4
- Filed
- Jan 6, 7:00 PM ET
- Accepted
- Jan 7, 9:00 PM ET
- Size
- 5.4 KB